Timothy J. Sangiovanni - Net Worth and Insider Trading
Timothy J. Sangiovanni Net Worth
The estimated net worth of Timothy J. Sangiovanni is at least $37,327 dollars as of 2024-12-28. Timothy J. Sangiovanni is the SVP, Corporate Controller of Zevra Therapeutics Inc and owns about 4,449 shares of Zevra Therapeutics Inc (ZVRA) stock worth over $37,327. Details can be seen in Timothy J. Sangiovanni's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Timothy J. Sangiovanni has not made any transactions after 2023-03-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Timothy J. Sangiovanni
Timothy J. Sangiovanni Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Timothy J. Sangiovanni owns 1 companies in total, including Zevra Therapeutics Inc (ZVRA) .
Click here to see the complete history of Timothy J. Sangiovanni’s form 4 insider trades.
Insider Ownership Summary of Timothy J. Sangiovanni
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ZVRA | Zevra Therapeutics Inc | 2023-03-10 | VP & Corporate Controller |
Timothy J. Sangiovanni Latest Holdings Summary
Timothy J. Sangiovanni currently owns a total of 1 stock. Timothy J. Sangiovanni owns 4,449 shares of Zevra Therapeutics Inc (ZVRA) as of March 10, 2023, with a value of $37,327.
Latest Holdings of Timothy J. Sangiovanni
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ZVRA | Zevra Therapeutics Inc | 2023-03-10 | 4,449 | 8.39 | 37,327 |
Holding Weightings of Timothy J. Sangiovanni
Timothy J. Sangiovanni Form 4 Trading Tracker
According to the SEC Form 4 filings, Timothy J. Sangiovanni has made a total of 3 transactions in Zevra Therapeutics Inc (ZVRA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Zevra Therapeutics Inc is the acquisition of 1,200 shares on March 10, 2023, which cost Timothy J. Sangiovanni around $4,968.
Insider Trading History of Timothy J. Sangiovanni
- 1
Timothy J. Sangiovanni Trading Performance
GuruFocus tracks the stock performance after each of Timothy J. Sangiovanni's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Timothy J. Sangiovanni is -13.03%. GuruFocus also compares Timothy J. Sangiovanni's trading performance to market benchmark return within the same time period. The performance of stocks bought by Timothy J. Sangiovanni within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Timothy J. Sangiovanni's insider trading performs compared to the benchmark.
Performance of Timothy J. Sangiovanni
Timothy J. Sangiovanni Ownership Network
Timothy J. Sangiovanni Owned Company Details
What does Zevra Therapeutics Inc do?
Who are the key executives at Zevra Therapeutics Inc?
Timothy J. Sangiovanni is the VP & Corporate Controller of Zevra Therapeutics Inc. Other key executives at Zevra Therapeutics Inc include VP Fin & Corp Controller R. Laduane Clifton , director & President and CEO Neil F. Mcfarlane , and CCO & EVP & Bus. Development Joshua Schafer .
Zevra Therapeutics Inc (ZVRA) Insider Trades Summary
Over the past 18 months, Timothy J. Sangiovanni made no insider transaction in Zevra Therapeutics Inc (ZVRA). Other recent insider transactions involving Zevra Therapeutics Inc (ZVRA) include a net purchase of 20,000 shares made by John B Bode , a net purchase of 20,000 shares made by Thomas Anderson , and a net purchase of 3,000 shares made by R. Laduane Clifton .
In summary, during the past 3 months, insiders sold 0 shares of Zevra Therapeutics Inc (ZVRA) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 0 shares of Zevra Therapeutics Inc (ZVRA) were sold and 44,000 shares were bought by its insiders, resulting in a net purchase of 44,000 shares.
Zevra Therapeutics Inc (ZVRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zevra Therapeutics Inc Insider Transactions
Timothy J. Sangiovanni Mailing Address
Above is the net worth, insider trading, and ownership report for Timothy J. Sangiovanni. You might contact Timothy J. Sangiovanni via mailing address: C/o Kempharm, Inc., 2500 Crosspark Rd, Ste E-126, Coralville Ia 52241.